$IQST - IQSTEL Issues Recap Shareholder Letter Highlighting

New Post Public Reply Private Reply Replies (0) Message Board
Lee Adams Lee Adams #18445
188
$IQST - IQSTEL Issues Recap Shareholder Letter Highlighting $2 Debt Reduction Per Share, $400 Million Run Rate in Q3 (Ahead of Schedule), and Analyst Coverage Targeting $18-$22 Price Range

Company Recaps Milestones After Two Months on NASDAQ: Accelerated Growth, Strengthened Balance Sheet, Launch of High-Margin Tech Products, and Strategic Acquisition of Globetopper


NEW YORK, July 21, 2025 /PRNewswire/ -- IQSTEL Inc. (NASDAQ: IQST) has released a shareholder letter reflecting on its strategic and financial achievements during its first two months trading on the NASDAQ. The letter outlines the company's accelerating growth trajectory, successful execution of its high-margin technology strategy, strengthened capital structure, and enhanced institutional visibility.

In this letter, IQSTEL's CEO shares key business highlights, including surpassing a $400 million revenue run rate earlier than projected, the launch of AI-powered platforms like IQ2Call.ai, and the addition of $60–70 million in revenue through the Globetopper acquisition. The company also emphasizes its $2-per-share debt reduction, improving shareholder value and positioning IQSTEL to achieve its long-term $1 billion revenue goal by 2027.

Dear Shareholders,

As we mark our second month trading on the NASDAQ, I want to take this opportunity to reflect on the tremendous progress we've made and share with you why we believe the road ahead for IQSTEL is not just promising — it's transformative. The Board of Directors and officers of the company are both excited and honored to have hit these major milestones. We remain fully committed to creating long-term shareholder value and driving the continued growth of the company.

A Strong Start to 2025 – Accelerating Toward a New Era

We've reported $128.8 million in preliminary unaudited revenue for the first half of 2025, with June alone contributing $27.3 million — a clear sign that our commercial momentum is not just holding strong, but accelerating.

Starting July 1st, we began consolidating revenues from our newly acquired subsidiary, Globetopper, which is expected to add an additional $5 to $6 million per month. With this acceleration, we now expect to surpass a $400 million revenue run rate during Q3, several months ahead of our original year-end target.

But we're not just growing our top line — we're strengthening our bottom line. Our strategy is focused on building a scalable, high-margin business model, and our recent launches of IQ2Call.ai and the upcoming AI-powered cybersecurity services through Cycurion are driving exactly that. These tech offerings are not only innovative — they are designed to increase both Net Income and Adjusted EBITDA, paving the way for sustainable, profitable growth.

To learn more about our revenue growth and projected run rate, click here.

Globetopper Acquisition – Strengthening Our Fintech Business

On July 1st, we completed the acquisition of Globetopper, a move that adds $60–70 million in annual revenue with positive EBITDA. This acquisition also plays a key role in relaunching our fintech division.

We are actively working on a plan to grow Globetopper's revenue to $100 million annually, with at least $1 million in EBITDA, further reinforcing our leadership in global telecom and fintech services. We are planning to reach a 400M run rate in Q3, with a revenue mix of 80% telecom and 20% fintech.

To learn more about the Acquisition of GlobeTopper, click here.

Independent Analyst Coverage – Market Recognition Growing

We are proud to be the subject of a new independent analyst report by Hills Research, which initiated coverage on IQSTEL with a price target range of $18 to $22 per share.

This endorsement came after extensive due diligence, including in-person meetings at our Florida office and deep analysis of our technology platform. This report reflects growing institutional awareness and validation of our strategy and value proposition.

To access the Hills Research Report, click here.

High-Margin Tech Products – The Future Is Now

In July, we launched IQ2Call.ai, our AI-powered call center platform featuring real-time voice AI, multilingual support, and adaptive scalability with zero wait times. IQ2Call targets the $750 billion global call center industry, delivering unmatched performance and compliance.

This is a transformative milestone in our vertical integration strategy. In both Spain and the U.S., IQ2Call is already being deployed, and we're currently closing deals that will accelerate adoption further.

To learn more information about our new product IQ2Call, click here.

Additionally, through our partnership with Cycurion, we're also preparing to enter the cybersecurity sector, delivering new era of AI-driven cybersecurity services tailored for the telecom industry. Thanks to our deep, long-standing relationships with hundreds of global telecom operators, we will be able to cross-sell these offerings and maximize return per customer.

To learn more information about our partnership with Cycurion, click here.

Strengthening Our Balance Sheet – A Healthier, Leaner IQSTEL

We recently reduced our debt by $6.9 million, converting part into common shares and the remainder into preferred equity — all of which is already reflected in our capital structure.

This means we've effectively eliminated around $2 of debt per share, creating significant shareholder value. These actions also reflect investor confidence in our long-term vision to become a $1 billion revenue company by 2027.

To learn more about our debt reduction, click here

Investor Access and Institutional Outreach

In early July, we released a comprehensive investor presentation outlining our strategy, business model, financials, and future vision. We are starting actively presenting to institutional investors and family offices, encouraging them to acquire and hold IQST shares directly on the open market — with no dilution involved.

To access to our Investors Deck, click here

Looking Ahead – Halfway to a Billion

From just $13 million in 2018 to nearly $300 million in 2024, our story has been one of strategic growth and bold execution.

Now, with a healthy balance sheet, a scalable telecom and fintech platform, and a pipeline of high-tech, high-margin products, we are well on our way to:

Achieving our $340 million 2025 revenue forecast
Exceeding a $400 million run rate in Q3
Ultimately reaching $1 billion in annual revenue by
Driving sustained growth in Net Income and Adjusted EBITDA
And this is just the beginning.

With your continued trust and support, IQSTEL is writing the next chapter in technology-driven telecom innovation — and you're part of it.

Sincerely,

Leandro Jose Iglesias
President & CEO
IQSTEL Inc. (Nasdaq: IQST)

About IQSTEL Inc.

IQSTEL Inc. (NASDAQ: IQST) is a multinational technology company providing advanced solutions across Telecom, High-Tech Telecom Services, Fintech, AI-Powered Telecom Platforms, and Cybersecurity. With operations in 21 countries and a team of 100 employees, IQSTEL serves a broad global customer base with high-value, high-margin services. Backed by a strong and scalable business platform, the company is forecasting $340 million in revenue for FY-2025, reinforcing its trajectory toward becoming a $1 billion tech-driven enterprise by 2027.

Use of Non-GAAP Financial Measures: The Company uses certain financial calculations such as Adjusted EBITDA, Return on Assets and Return on Equity as factors in the measurement and evaluation of the Company's operating performance and period-over-period growth. The Company derives these financial calculations on the basis of methodologies other than generally accepted accounting principles ("GAAP" , primarily by excluding from a comparable GAAP measure certain items the Company does not consider to be representative of its actual operating performance. These financial calculations are "non-GAAP financial measures" as defined under the SEC rules. The Company uses these non-GAAP financial measures in operating its business because management believes they are less susceptible to variances in actual operating performance that can result from the excluded items, other infrequent charges and currency fluctuations. The Company presents these financial measures to investors because management believes they are useful to investors in evaluating the primary factors that drive the Company's core operating performance and provide greater transparency into the Company's results of operations. However, items that are excluded and other adjustments and assumptions that are made in calculating these non-GAAP financial measures are significant components in understanding and assessing the Company's financial performance. These non-GAAP financial measures should be evaluated in conjunction with, and are not a substitute for, the Company's GAAP financial measures. Further, because these non-GAAP financial measures are not determined in accordance with GAAP, and are thus susceptible to varying calculations, the non-GAAP financial measures, as presented, may not be comparable to other similarly-titled measures of other companies.

Adjusted EBITDA is not a recognized accounting measurement under GAAP; it should not be considered as an alternative to net income, as a measure of operating results, or as an alternative to cash flow as a measure of liquidity. It is presented here not as an alternative to net income, but rather as a measure of the Company's operating performance. Adjusted EBITDA excludes, in addition to non-operational expenses like interest expenses, taxes, depreciation and amortization; items that we believe are not indicative of our operating performance, such as:

Change in Fair Value of Derivative Liabilities: These adjustments reflect unrealized gains or losses that are non-operational and subject to market volatility.
Loss on Settlement of Debt: This represents non-recurring expenses associated with specific financing activities and does not impact ongoing business operations.
Stock-Based Compensation: As a non-cash expense, this adjustment eliminates variability caused by equity-based incentives.
The Company believes Adjusted EBITDA offers a clearer view of the cash-generating potential of its business, excluding non-recurring, non-cash, and non-operational impacts. Management believes that Adjusted EBITDA is useful in evaluating the Company's operating performance compared to that of other companies in its industry because the calculation of Adjusted EBITDA generally eliminates the effects of financing, income taxes, non-cash and certain other items that may vary for different companies for reasons unrelated to overall operating performance and also believes this information is useful to investors.

Safe Harbor Statement: Statements in this news release may be "forward-looking statements". Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions, or any other information relating to our future activities or other future events or conditions. Words such as "anticipate," "believe," "estimate," "expect," "intend", "could" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates, and projections about our business based partly on assumptions made by management. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: our ability to successfully market our products and services; our continued ability to pay operating costs and ability to meet demand for our products and services; the amount and nature of competition from other telecom products and services; the effects of changes in the cybersecurity and telecom markets; our ability to successfully develop new products and services; our ability to complete complementary acquisitions and dispositions that benefit our company; our success establishing and maintaining collaborative, strategic alliance agreements with our industry partners; our ability to comply with applicable regulations; our ability to secure capital when needed; and the other risks and uncertainties described in our prior filings with the Securities and Exchange Commission.

These statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Therefore, actual outcomes and results may and are likely to differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release, and IQSTEL Inc. undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

For more information, please visit www.IQSTEL.com.

https://c212.net/c/img/favicon.png?sn=FL33687...2025-07-21 View original content to download multimedia:https://www.prnewswire.com/news-releases/iqst---iqstel-issues-recap-shareholder-letter-highlighting-2-debt-reduction-per-share-400-million-run-rate-in-q3-ahead-of-schedule-and-analyst-coverage-targeting-1822-price-range-302509513.html

SOURCE iQSTEL
Scroll down for more posts ▼

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Oasis Management Proposes Governance Change for Kobayashi Pharma

Updated Category News Views 243

Oasis Management Advocates for Enhanced Governance at Kobayashi Pharma Oasis Management Company Ltd. (“Oasis”) has emerged as a significant voice among shareholders of Kobayashi Pharmaceutical Co., Ltd. (4967 JT). Holding over 7.5% of the company, Oasis is actively pushing for essential changes in leadership and independent oversight to address pressing governance...

Continue Reading
Synopsys Faces Legal Challenges Amid Stockholder Concerns

Updated Category News Views 235

Understanding the Recent Class Action Lawsuit Against Synopsys Recently, concerns have emerged regarding Synopsys, Inc. as a class action lawsuit was filed alleging serious misrepresentations concerning the company’s financial health. Investors who have been affected are encouraged to seek guidance to explore their legal rights and options that may arise from this...

Continue Reading
Cumulus Media's Engaging Coverage of 2025 NCAA Basketball Events

Updated Category News Views 228

Thrilling NCAA Basketball Coverage by Cumulus Media Cumulus Media’s Westwood One is gearing up for an exciting audio experience during the 2025 NCAA Men’s and Women’s Basketball tournaments. With the largest radio network in the country, Westwood One will deliver comprehensive coverage that connects die-hard sports fans across a plethora of platforms. Connecting...

Continue Reading
ByteDance's Ambitious AI Chip Investment Plans for 2025

Updated Category News Views 1644

ByteDance's Strategic Investment in AI Technology ByteDance, the renowned owner of TikTok, is making significant strides in artificial intelligence by planning to invest more than $12 billion on AI infrastructure in the upcoming years. This ambitious investment highlights the company's commitment to harnessing cutting-edge technology for growth. According to reports, the...

Continue Reading
Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit

Updated Category News Views 130

Investors of ModivCare, Inc. Urged to Join Class Action Lawsuit The law firm Robbins Geller Rudman & Dowd LLP is calling for investors of ModivCare, Inc. (NASDAQ: MODV) who have experienced significant financial losses to take action. Understanding the Class Action Lawsuit The upcoming class action lawsuit, titled Kalera v. ModivCare, Inc., brings serious allegations...

Continue Reading